3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia
3
Recurrence
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Biphenotypic, Acute
1
Interventions
Cyclophosphamide
23
fludarabine
14
Rituximab
14
Specimen Handling
9
Magnetic Resonance Spectroscopy
8
Doxorubicin
7
pirtobrutinib
6
Vincristine
6
Prednisone
6
polatuzumab vedotin
5
obinutuzumab
5
Biopsy
5
zanubrutinib
4
glofitamab
4
Nivolumab
4
Etoposide
4
Dexamethasone
4
tazemetostat
3
tafasitamab
3
pembrolizumab
3
ibrutinib
3
fludarabine phosphate
3
acalabrutinib
3
Leukapheresis
3
Bendamustine Hydrochloride
3
venetoclax
2
pomalidomide
2
loncastuximab tesirine
2
etoposide phosphate
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Inotuzumab Ozogamicin
×
90 days
×
Clear all
No trials found.